Loading...

INO INOVIO PHARMACEUTICALS INC Capital Structure Changes 8-K Filing

NV P

N

INOVIO PHARMACEUTICALS INC

(INO)

2026 8-K

Financial Results

Stock Offering Details

Sales Agreement Termination

Financial Results Announcement

Warrant Amendment

FDA BLA Acceptance

Stock Offering Announcement

8-K Filing Summary

Equity Offerings

Financial Statements

Financial Results

Financial Results

Financial Results Announcement

Grant of Performance-Based ...

Financial Results Announcement

Underwriting Agreement for ...

Reverse Stock Split

Stock Split and Amendment A...

Financial Results Announcement

FDA Feedback on Clinical Tr...

Financial Results Announcement

Settlement of Stockholder D...

Compensation Committee adop...

Earnings Reports

Financial Results Announcement

Costs Associated with Exit ...

External Links:

On January 27, 2026, Inovio Pharmaceuticals amended its Series A warrants to extend the expiration date to March 31, 2026, allowing the purchase of up to 13,564,268 shares at $1.75 each.

AI Assistant

INOVIO PHARMACEUTICALS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.